{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:49:05Z","timestamp":1790092145792,"version":"4.0.1"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01249","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T14:11:08Z","timestamp":1592575868000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis"],"prefix":"10.3389","volume":"11","author":[{"given":"Asl\u0131han","family":"Avano\u01e7lu G\u00fcler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Wanda","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bellando-Randone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nella","family":"Prevete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman","family":"Tufan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Manetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amato","family":"de Paulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5301\/jsrd.5000249","article-title":"Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities","volume":"2","author":"Varga","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"B2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/cei.13238","article-title":"The immunopathogenesis of fibrosis in systemic sclerosis","volume":"195","author":"Brown","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/2397198318783930","article-title":"Anti-nuclear autoantibodies in systemic sclerosis: news and perspectives","volume":"3","author":"Hamaguchi","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR scleroderma trials and research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41584-019-0184-z","article-title":"Emerging targets of disease-modifying therapy for systemic sclerosis","volume":"15","author":"Volkmann","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/path.4108","article-title":"Hanging in the balance: endogenous anti-inflammatory mechanisms in tissue repair and fibrosis","volume":"229","author":"Ariel","year":"2013","journal-title":"J Pathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12016-019-08754-9","article-title":"Resolvins: emerging players in autoimmune and inflammatory diseases","volume":"58","author":"Abdolmaleki","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00418-004-0695-8","article-title":"A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution","volume":"122","author":"Serhan","year":"2004","journal-title":"Histochem Cell Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular circuits of resolution: formation and actions of resolvins and protectins","volume":"174","author":"Bannenberg","year":"2005","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2146\/ajhp080411","article-title":"Therapeutic potential of n-3 polyunsaturated fatty acids in disease","volume":"66","author":"Fetterman","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.4049\/jimmunol.1502268","article-title":"Resolvin D3 is dysregulated in arthritis and reduces arthritic inflammation","volume":"197","author":"Arnardottir","year":"2016","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/rheumatology\/kez072","article-title":"Aspirin triggered resolvin D1 reduces inflammation and restores saliva secretion in a sjogren's syndrome mouse model","volume":"58","author":"Dean","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejphar.2015.08.050","article-title":"EPA- and DHA-derived resolvins' actions in inflammatory bowel disease","volume":"785","author":"Schwanke","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e12628","DOI":"10.14814\/phy2.12628","article-title":"17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice","volume":"3","author":"Yatomi","year":"2015","journal-title":"Physiol Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3760\/cma.j.issn.0376-2491.2019.14.015","article-title":"[Role and related mechanism of resolvin D1 in lung ischemia reperfusion injury in rats]","volume":"99","author":"Xia","year":"2019","journal-title":"Zhonghua yi xue za zhi"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"eaan1471","DOI":"10.1126\/scisignal.aan1471","article-title":"A cluster of immunoresolvents links coagulation to innate host defense in human blood","volume":"10","author":"Norris","year":"2017","journal-title":"Sci Signal"},{"key":"B23","doi-asserted-by":"publisher","first-page":"eaax4895","DOI":"10.1126\/sciadv.aax4895","article-title":"Resolution metabolomes activated by hypoxic environment","volume":"5","author":"Norris","year":"2019","journal-title":"Sci Adv"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.ajpath.2012.01.028","article-title":"Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs","volume":"180","author":"Krishnamoorthy","year":"2012","journal-title":"Am J Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.phrs.2017.09.024","article-title":"New perspectives in cancer: modulation of lipid metabolism and inflammation resolution","volume":"128","author":"Prevete","year":"2018","journal-title":"Pharmacol Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1084\/jem.20150225","article-title":"Identification of resolvin D2 receptor mediating resolution of infections and organ protection","volume":"212","author":"Chiang","year":"2015","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.chembiol.2012.11.010","article-title":"Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents","volume":"20","author":"Dalli","year":"2013","journal-title":"Chem Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J Exp Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.4049\/jimmunol.178.6.3912","article-title":"Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation","volume":"178","author":"Arita","year":"2007","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11926-017-0630-3","article-title":"Innate immunity in systemic sclerosis","volume":"19","author":"Dowson","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrd.2016.39","article-title":"Resolution of inflammation: a new therapeutic frontier","volume":"15","author":"Fullerton","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"B33","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1182\/blood-2007-11-122598","article-title":"Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets","volume":"112","author":"Dona","year":"2008","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.4049\/jimmunol.1103652","article-title":"Resolvin E2 formation and impact in inflammation resolution","volume":"188","author":"Oh","year":"2012","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"12750","DOI":"10.1096\/fj.201900283R","article-title":"Resolvin E3 attenuates allergic airway inflammation via the interleukin-23-interleukin-17A pathway","volume":"33","author":"Sato","year":"2019","journal-title":"FASEB J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1161\/ATVBAHA.112.249508","article-title":"Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions","volume":"32","author":"Norling","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.plefa.2016.01.001","article-title":"Resolvin D3 multi-level proresolving actions are host protective during infection","volume":"138","author":"Norris","year":"2018","journal-title":"Prostag Leukot Essent Fatty Acids"},{"key":"B38","doi-asserted-by":"publisher","first-page":"18972","DOI":"10.1038\/srep18972","article-title":"Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance","volume":"6","author":"Winkler","year":"2016","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.4049\/jimmunol.177.9.5902","article-title":"Resolvin D series and protectin D1 mitigate acute kidney injury","volume":"177","author":"Duffield","year":"2006","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1172\/JCI42545","article-title":"Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation","volume":"121","author":"Oh","year":"2011","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3389\/fimmu.2018.00785","article-title":"Resolvin D2 restrains Th1 immunity and prevents alveolar bone loss in murine periodontitis","volume":"9","author":"Mizraji","year":"2018","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"353ra111","DOI":"10.1126\/scitranslmed.aaf7483","article-title":"Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses","volume":"8","author":"Chiurchiu","year":"2016","journal-title":"Sci Transl Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"14983","DOI":"10.1073\/pnas.1206641109","article-title":"Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation","volume":"109","author":"El Kebir","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B46","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.4049\/jimmunol.1100225","article-title":"Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype","volume":"187","author":"Titos","year":"2011","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1096\/fj.14-265363","article-title":"Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice","volume":"29","author":"Akagi","year":"2015","journal-title":"FASEB J"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e58258","DOI":"10.1371\/journal.pone.0058258","article-title":"A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation","volume":"8","author":"Hsiao","year":"2013","journal-title":"PLoS ONE"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1016\/j.ajpath.2015.08.008","article-title":"Resolvin D1 reduces emphysema and chronic inflammation","volume":"185","author":"Hsiao","year":"2015","journal-title":"Am J Pathol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"318621","DOI":"10.1155\/2012\/318621","article-title":"Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis","volume":"2012","author":"Settimio","year":"2012","journal-title":"Mediat Inflamm"},{"key":"B51","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.intimp.2012.08.005","article-title":"Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC\/Nga mice","volume":"14","author":"Kim","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.4049\/jimmunol.1103483","article-title":"Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells","volume":"189","author":"Ramon","year":"2012","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.4049\/jimmunol.180.5.3512","article-title":"Resolvin E1 metabolome in local inactivation during inflammation-resolution","volume":"180","author":"Hong","year":"2008","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/eji.201545673","article-title":"Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production","volume":"46","author":"Kim","year":"2016","journal-title":"Eur J Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"10525","DOI":"10.1074\/jbc.M112.340612","article-title":"Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid","volume":"287","author":"Isobe","year":"2012","journal-title":"J Biol Chem"},{"key":"B56","doi-asserted-by":"publisher","first-page":"105877","DOI":"10.1016\/j.intimp.2019.105877","article-title":"RvD1 ameliorates LPS-induced acute lung injury via the suppression of neutrophil infiltration by reducing CXCL2 expression and release from resident alveolar macrophages","volume":"76","author":"Zhang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"eaao3089","DOI":"10.1126\/scitranslmed.aao3089","article-title":"Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis","volume":"10","author":"Maugeri","year":"2018","journal-title":"Sci Transl Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/rheumatology\/ker520","article-title":"Neutrophil-derived reactive oxygen species in SSc","volume":"51","author":"Barnes","year":"2012","journal-title":"Rheumatology (Oxford, England)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.semarthrit.2008.10.009","article-title":"Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature","volume":"40","author":"Kowal-Bielecka","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"B60","first-page":"349","article-title":"Relationship between abnormalities on high-resolution computerized tomography, pulmonary function, and bronchoalveolar lavage in progressive systemic sclerosis","volume":"33","author":"Cakmak","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/BOR.0b013e3283126985","article-title":"Scleroderma lung disease: evolving understanding in light of newer studies","volume":"20","author":"Antoniou","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.autrev.2008.07.015","article-title":"Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE)","volume":"8","author":"Janko","year":"2008","journal-title":"Autoimmun Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e112100","DOI":"10.1371\/journal.pone.0112100","article-title":"Impaired clearance of early apoptotic cells mediated by inhibitory IgG antibodies in patients with primary sjogren's syndrome","volume":"9","author":"Manoussakis","year":"2014","journal-title":"PLoS ONE"},{"key":"B64","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/imcb.12217","article-title":"Efferocytosis capacities of blood monocyte-derived macrophages in systemic sclerosis","volume":"97","author":"Ballerie","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1172\/JCI31422","article-title":"Altered macrophage differentiation and immune dysfunction in tumor development","volume":"117","author":"Sica","year":"2007","journal-title":"J Clin Invest"},{"key":"B66","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.bbadis.2012.12.001","article-title":"Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair","volume":"1832","author":"Lech","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B68","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/imm.12910","article-title":"Implications of macrophage polarization in autoimmunity","volume":"154","author":"Funes","year":"2018","journal-title":"Immunology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4049\/jimmunol.175.1.342","article-title":"Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences","volume":"175","author":"Stout","year":"2005","journal-title":"J Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"R128","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B71","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12931-018-0891-z","article-title":"A circulating cell population showing both M1 and M2 monocyte\/macrophage surface markers characterizes systemic sclerosis patients with lung involvement","volume":"19","author":"Trombetta","year":"2018","journal-title":"Respir Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1136\/annrheumdis-2018-213648","article-title":"Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis","volume":"77","author":"Soldano","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1096\/fj.201600144RR","article-title":"D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization","volume":"30","author":"Pope","year":"2016","journal-title":"FASEB J"},{"key":"B74","doi-asserted-by":"publisher","first-page":"eaam8458","DOI":"10.1126\/scitranslmed.aam8458","article-title":"Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8","volume":"10","author":"Ah Kioon","year":"2018","journal-title":"Sci Transl Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e98380","DOI":"10.1172\/jci.insight.98380","article-title":"pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis","volume":"3","author":"Kafaja","year":"2018","journal-title":"JCI Insight"},{"key":"B76","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4049\/jimmunol.174.1.244","article-title":"Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood","volume":"174","author":"Zabel","year":"2005","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1084\/jem.20041310","article-title":"Role of chemr23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin","volume":"201","author":"Vermi","year":"2005","journal-title":"J Exp Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1161\/ATVBAHA.119.312386","article-title":"Hematopoietic chemr23 (chemerin receptor 23) fuels atherosclerosis by sustaining an M1 macrophage-phenotype and guidance of plasmacytoid dendritic cells to murine lesions-brief report","volume":"39","author":"van der Vorst","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B79","first-page":"2838","article-title":"Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis","volume":"27","author":"Sato","year":"2000","journal-title":"J Rheumatol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13417","article-title":"Novel insights into dendritic cells in the pathogenesis of systemic sclerosis","author":"Carvalheiro","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"154799","DOI":"10.1016\/j.cyto.2019.154799","article-title":"Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis","volume":"125","author":"Gasparini","year":"2020","journal-title":"Cytokine"},{"key":"B82","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/archderm.132.7.802","article-title":"Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis","volume":"132","author":"Salmon-Ehr","year":"1996","journal-title":"Arch Dermatol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00011-015-0806-0","article-title":"Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis","volume":"64","author":"Huang","year":"2015","journal-title":"Inflamm Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/art.37706","article-title":"Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis","volume":"65","author":"Fuschiotti","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B85","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"B87","doi-asserted-by":"publisher","first-page":"046013","DOI":"10.1088\/1752-7155\/10\/4\/046013","article-title":"Th-17 cytokines and interstitial lung involvement in systemic sclerosis","volume":"10","author":"Rolla","year":"2016","journal-title":"J Breath Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"R4","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","volume":"16","author":"Yang","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B89","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.imlet.2017.09.007","article-title":"Is there a role for IL-17 in the pathogenesis of systemic sclerosis?","volume":"195","author":"Chizzolini","year":"2018","journal-title":"Immunol Lett"},{"key":"B90","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","volume":"11","author":"Gourh","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B91","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/1756-185X.12290","article-title":"Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis","volume":"17","author":"Olewicz-Gawlik","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"B92","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.4049\/jimmunol.181.7.4534","article-title":"Bone marrow-derived dendritic cells generated in the presence of resolvin E1 induce apoptosis of activated CD4+ T cells","volume":"181","author":"Vassiliou","year":"2008","journal-title":"J Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/ni.1627","article-title":"Resolvin E1 regulates interleukin 23, interferon-\u03b3 and lipoxin A4 to promote the resolution of allergic airway inflammation","volume":"9","author":"Haworth","year":"2008","journal-title":"Nat Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1002\/art.23806","article-title":"Endothelial\/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis","volume":"58","author":"Manetti","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1002\/art.22847","article-title":"B cell infiltration in systemic sclerosis-associated interstitial lung disease","volume":"56","author":"Lafyatis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B96","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.revmed.2016.02.016","article-title":"Role of B cells in the pathogenesis of systemic sclerosis","volume":"38","author":"Sanges","year":"2017","journal-title":"Rev Med Interne"},{"key":"B97","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJMra1507638","article-title":"Raynaud's phenomenon","volume":"375","author":"Wigley","year":"2016","journal-title":"N Engl J Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"v45","DOI":"10.1093\/rheumatology\/kex199","article-title":"Points to consider-Raynaud's phenomenon in systemic sclerosis","volume":"56","author":"Cutolo","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"B99","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.3389\/fimmu.2018.02045","article-title":"Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed?","volume":"9","author":"Bruni","year":"2018","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nrrheum.2014.195","article-title":"A vascular mechanistic approach to understanding raynaud phenomenon","volume":"11","author":"Flavahan","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/00000542-200106000-00030","article-title":"Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury","volume":"94","author":"Collard","year":"2001","journal-title":"Anesthesiology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1159\/000489241","article-title":"Current mechanistic concepts in ischemia and reperfusion injury","volume":"46","author":"Wu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1111\/bph.14212","article-title":"Resolvin D1 attenuates liver ischaemia\/reperfusion injury through modulating thioredoxin 2-mediated mitochondrial quality control","volume":"175","author":"Kang","year":"2018","journal-title":"Br J Pharmacol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3892\/etm.2014.1641","article-title":"Resolvin E1 reduces hepatic fibrosis in mice with schistosoma japonicum infection","volume":"7","author":"Qiu","year":"2014","journal-title":"Exp Ther Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/path.4050","article-title":"Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation","volume":"228","author":"Qu","year":"2012","journal-title":"J Pathol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2015.04.003","article-title":"Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function","volume":"84","author":"Kain","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12931-018-0834-8","article-title":"Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology","volume":"19","author":"Rout-Pitt","year":"2018","journal-title":"Respir Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/01.bor.0000139310.77347.9c","article-title":"Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis","volume":"16","author":"Postlethwaite","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"L1013","DOI":"10.1152\/ajplung.00415.2018","article-title":"Resolvin D1 attenuates mechanical stretch-induced pulmonary fibrosis via epithelial-mesenchymal transition","volume":"316","author":"Yang","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5301\/jsrd.5000207","article-title":"Emerging strategies for treatment of systemic sclerosis","volume":"1","author":"Khanna","year":"2016","journal-title":"J Scleroderma Relat Disord"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T14:11:11Z","timestamp":1592575871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":111,"alternative-id":["10.3389\/fimmu.2020.01249"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01249","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]},"article-number":"1249"}}